Detalles de la búsqueda
1.
Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination-deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial.
Trials
; 25(1): 301, 2024 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38702828
Resultados
1 -
1
de 1
1
Próxima >
>>